288
Participants
Start Date
May 31, 2008
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
Ciprofloxacin (Cipro Inhale, BAYQ3939)
32.5 mg ciprofloxacin DPI corresponding to 50 mg Ciprofloxacin PulmoSphere Inhalation powder twice a day for 28 days
Placebo
50 mg matching placebo powder formulation twice a day for 28 days
Ciprofloxacin (Cipro Inhale, BAYQ3939)
48.75 mg ciprofloxacin DPI corresponding to 75 mg Ciprofloxacin PulmoSphere Inhalation powder twice a day for 28 days (Arm 3 and Arm 4 was introduced after amendment 2)
Placebo
75 mg matching placebo powder formulation twice a day for 28 days (Arm 3 and Arm 4 was introduced after amendment 2)
Copenhagen
Parkville
Clayton
Brisbane
Chermside
South Brisbane
Adelaide
Nedlands
Valhalla
New Hyde Park
Berlin
Albany
Philadelphia
Charlottesville
Durham
Charleston
Jacksonville
Orlando
Orlando
Orlando
Miami
Knoxville
Jackson
Louisville
Toledo
Indianapolis
Ann Arbor
Kalamazoo
Madison
Glenview
Maywood
Frankfurt am Main
Chicago
Chicago
Little Rock
Oklahoma City
Oklahoma City
Tulsa
San Antonio
Austin
Aurora
München
Salt Lake City
Phoenix
Tucson
Las Vegas
Los Angeles
Los Angeles
Los Angeles
Orange
Ventura
San Francisco
Seattle
San Diego
Hartford
New Haven
Augusta
Iowa City
Lexington
Boston
Boston
Livingston
Long Branch
Morristown
Somerville
Akron
Cincinnati
Hershey
Philadelphia
St. John's
Hamilton
London
Montreal
Leipzig
Haifa
Jerusalem
Petah Tikva
Tel Litwinsky
Oslo
Gothenburg
Lund
Uppsala
Cambridge
Southampton
Belfast
Birmingham